Testing changes in jawbone problems in adults
Part of Bones, joints & muscles, Mouth & dental clinical trials.
This study looks at what changes happen in the jawbone in people with osteonecrosis of the jaw (a damaged jawbone area), whether or not they take certain cancer/bone medicines. It may help doctors better understand the condition and how it behaves over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years of age or older
- You can be taking anti-bone/anti-cancer treatment (ART) or not
- You can have osteonecrosis of the jaw (MRONJ) or not
- Do not smoke more than 10 cigarettes per day
- You must not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with medication-related osteonecrosis of the jaw (a bone condition often caused by certain cancer or osteoporosis medicines) using imaging scans to understand how the bone changes over time. The goal is to better predict outcomes and improve treatment.
This study looks at how a specific jaw problem (osteonecrosis) may happen in people taking bone-strengthening medications. It aims to better understand and manage this side effect.
This trial compares two surgical techniques for treating medication-related jaw bone problems (MRONJ): one using a special vibrating tool (piezoelectric) and the other using conventional tools. It aims to see which approach leads to better healing and fewer complications.
This trial tests whether using a special blood product (leukocyte- and platelet-rich fibrin, or L-PRF) during surgery for a jawbone condition called MRONJ helps improve healing. Patients who need surgery under general anesthesia for advanced MRONJ may be able to join.
This study looks at your risk of developing a rare jaw bone problem from certain bone-strengthening medications before, during, and after a needed dental procedure. Your participation could help find early warning signs and improve prevention.
This study looks at people who have jaw bone damage (osteonecrosis) caused by medications. Researchers want to understand what treatments and risk factors are linked to this condition to help improve care.
Hear when a new Osteonecrosis of the Jaw trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.